6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	KKR Appoints Lauren Goodwin as Chief Investment Strategist for Global Wealth
Just now	Roman DBDR Acquisition Corp. II Appoints Randolph C. Read to Board of Directors, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions
Just now	Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Just now	Skycorp Solar Group Limited Announces Regaining Compliance with Nasdaq Minimum Bid Price Requirement
Just now	AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

About

Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) — investor relations, events, news, and company updates on 6ix.

Latest News

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Financials

Revenue

$677.56 M

Market Cap

$3.79 B

P/E Ratio

66.07

EPS

0.75

Community Chat

Ask AI